Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Receivables - Net (2021 - 2025)

Historic Receivables - Net for Core Scientific (CORZ) over the last 5 years, with Q1 2025 value amounting to $1.0 million.

  • Core Scientific's Receivables - Net fell 803.97% to $1.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.0 million, marking a year-over-year decrease of 803.97%. This contributed to the annual value of $1.0 million for FY2024, which is 239.76% up from last year.
  • Per Core Scientific's latest filing, its Receivables - Net stood at $1.0 million for Q1 2025, which was down 803.97% from $1.0 million recorded in Q4 2024.
  • Core Scientific's Receivables - Net's 5-year high stood at $6.2 million during Q3 2024, with a 5-year trough of $168000.0 in Q1 2022.
  • For the 5-year period, Core Scientific's Receivables - Net averaged around $1.7 million, with its median value being $1.1 million (2023).
  • In the last 5 years, Core Scientific's Receivables - Net plummeted by 8306.8% in 2022 and then skyrocketed by 53988.44% in 2024.
  • Core Scientific's Receivables - Net (Quarter) stood at $1.4 million in 2021, then tumbled by 83.07% to $234000.0 in 2022, then surged by 327.78% to $1.0 million in 2023, then grew by 2.4% to $1.0 million in 2024, then decreased by 0.68% to $1.0 million in 2025.
  • Its Receivables - Net stands at $1.0 million for Q1 2025, versus $1.0 million for Q4 2024 and $6.2 million for Q3 2024.